Abpro Holdings (ABPO) Receivables - Net (2023 - 2026)
Abpro Holdings' (ABPO) quarterly Receivables - Net came in at $183000.0 in Q1 2026, down 44.71% YoY from $331000.0 in Q1 2025, and little changed on a QoQ basis from $183000.0 in Q4 2025.
Abpro Holdings (ABPO) Receivables - Net (2023 - 2026) Analysis & Trends
Abpro Holdings (ABPO) has 4 years of Receivables - Net data on file, last reported at $183000.0 in Q1 2026.
- Quarterly Receivables - Net fell 44.71% year-over-year to $183000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $183000.0 (down 44.71% YoY) and the FY2025 annual result came in at $183000.0, changed 0.0% from the prior year.
- Receivables - Net held at $183000.0 in Q1 2026, from $183000.0 in the prior quarter.
- In the past five years, Receivables - Net ranged from a high of $342000.0 in Q2 2025 to a low of $88000.0 in Q4 2023.
- A 4-year average of $225857.1 and a median of $183000.0 in 2024 frame the typical range for Receivables - Net.
- Annual changes were most pronounced in 2024 — Receivables - Net surged 107.95% — and 2026, when it slumped 44.71%.
- Tracing ABPO's Receivables - Net over 4 years: stood at $88000.0 in 2023, then surged by 107.95% to $183000.0 in 2024, then changed by 0.0% to $183000.0 in 2025, then changed by 0.0% to $183000.0 in 2026.
- The last three Receivables - Net figures came in at $183000.0 (Q1 2026), $183000.0 (Q4 2025), and $271000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Abpro Holdings | 1.14 Mn | 1.14 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 183,000.00 |
| Mar 31, 2026 | 183,000.00 |
| Dec 31, 2025 | 183,000.00 |
| Dec 31, 2025 | 183,000.00 |
| Sep 30, 2025 | 271,000.00 |
| Sep 30, 2025 | 271,000.00 |
| Jun 30, 2025 | 342,000.00 |
| Jun 30, 2025 | 342,000.00 |
| Mar 31, 2025 | 331,000.00 |
| Mar 31, 2025 | 331,000.00 |
| Dec 31, 2024 | 183,000.00 |
| Dec 31, 2024 | 183,000.00 |
| Dec 31, 2023 | 88,000.00 |
| Dec 31, 2023 | 88,000.00 |